BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 36615316)

  • 1. Drug Resistance: The Role of Exosomal miRNA in the Microenvironment of Hematopoietic Tumors.
    Cariello M; Squilla A; Piacente M; Venutolo G; Fasano A
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Exosomal miRNAs and the Tumor Microenvironment in Drug Resistance.
    Santos P; Almeida F
    Cells; 2020 Jun; 9(6):. PubMed ID: 32545155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging roles of exosomes in anti-cancer drug resistance and tumor progression: An insight towards tumor-microenvironment interaction.
    Jena BC; Mandal M
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188488. PubMed ID: 33271308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of exosomes and miRNAs in drug-resistance of cancer cells.
    Bach DH; Hong JY; Park HJ; Lee SK
    Int J Cancer; 2017 Jul; 141(2):220-230. PubMed ID: 28240776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes decrease sensitivity of breast cancer cells to adriamycin by delivering microRNAs.
    Mao L; Li J; Chen WX; Cai YQ; Yu DD; Zhong SL; Zhao JH; Zhou JW; Tang JH
    Tumour Biol; 2016 Apr; 37(4):5247-56. PubMed ID: 26555545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
    Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
    Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
    [No Abstract]   [Full Text] [Related]  

  • 7. The Role of Exosomal MicroRNAs in the Tumor Microenvironment of Breast Cancer.
    Liu Q; Peng F; Chen J
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31395836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal cancer drug resistance: the role of exosomal miRNAs.
    Salehi M; Vafadar A; Khatami SH; Taheri-Anganeh M; Vakili O; Savardashtaki A; Negahdari B; Naeli P; Behrouj H; Ghasemi H; Movahedpour A
    Mol Biol Rep; 2022 Mar; 49(3):2421-2432. PubMed ID: 34850336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Find new channel for overcoming chemoresistance in cancers: Role of stem cells-derived exosomal microRNAs.
    Hussein GM; Mohammed SM; Faris M; Mohammed A; Kadhim MJ; Awadh SA; Ajam WH; Jalil AT
    Int J Biol Macromol; 2022 Oct; 219():530-537. PubMed ID: 35948201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal miRNAs in the microenvironment of pancreatic cancer.
    Zou X; Huang Z; Guan C; Shi W; Gao J; Wang J; Cui Y; Wang M; Xu Y; Zhong X
    Clin Chim Acta; 2023 Apr; 544():117360. PubMed ID: 37086943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal mRNAs and lncRNAs involved in multiple myeloma resistance to bortezomib.
    Tang JX; Chen Q; Li Q; He YH; Xiao D
    Cell Biol Int; 2021 May; 45(5):965-975. PubMed ID: 33372728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of exosomes and "exosomal shuttle microRNA" in tumorigenesis and drug resistance.
    Zhao L; Liu W; Xiao J; Cao B
    Cancer Lett; 2015 Jan; 356(2 Pt B):339-46. PubMed ID: 25449429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional roles of exosomal miRNAs in multi-drug resistance in cancer chemotherapeutics.
    Mowla M; Hashemi A
    Exp Mol Pathol; 2021 Feb; 118():104592. PubMed ID: 33296693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging role of exosomes and exosomal microRNA in cancer: pathophysiology and clinical potential.
    Elewaily MI; Elsergany AR
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):637-648. PubMed ID: 33511427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes and exosomal RNAs in breast cancer: A status update.
    Lakshmi S; Hughes TA; Priya S
    Eur J Cancer; 2021 Feb; 144():252-268. PubMed ID: 33373870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Extracellular Vesicles in Hematological Malignancies.
    Raimondo S; Corrado C; Raimondi L; De Leo G; Alessandro R
    Biomed Res Int; 2015; 2015():821613. PubMed ID: 26583135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes in the tumor microenvironment as mediators of cancer therapy resistance.
    Li I; Nabet BY
    Mol Cancer; 2019 Mar; 18(1):32. PubMed ID: 30823926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomal miRNAs as a Promising Source of Biomarkers in Colorectal Cancer Progression.
    Bakhsh T; Alhazmi S; Alburae NA; Farsi A; Alzahrani F; Choudhry H; Bahieldin A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal miRNAs in the Tumor Microenvironment of Multiple Myeloma.
    Alipoor SD; Chang H
    Cells; 2023 Mar; 12(7):. PubMed ID: 37048103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNAs mediated drug resistance in hematological malignancies.
    Peixoto da Silva S; Caires HR; Bergantim R; GuimarĂ£es JE; Vasconcelos MH
    Semin Cancer Biol; 2022 Aug; 83():283-302. PubMed ID: 33757848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.